In another report, Mazur et al. showed that SMYD3 deficiency inhibits tumor development in mouse models of pancreatic ductal adenocarcinoma and lung adenocarcinoma, demonstrating that SMYD3 activity promotes the formation of RAS-driven carcinomas [15]. The gene discussed is SMYD3; the disease is neoplasm.